arrow
A

Artur Veloso

sinai health system toronto
H指数:22
被引数:2,354

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Genome-wide CRISPR screens map synthetic lethal interactions across recurrent cancer driver alterations

全基因组CRISPR筛选绘制复发性癌症驱动基因改变中的合成致死相互作用

2026-09-010
PRE
Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas
2024-04-011
PRE
Guiding ATR and PARP inhibitor combinations with chemogenomic screens

用化学基因组学筛选指导ATR和PARP抑制剂组合

2022-07-0126
OA
RP-3500: A Novel, Potent, and Selective ATR Inhibitor that is Effective in Preclinical Models as a Monotherapy and in Combination with PARP Inhibitors
2021-12-1557
OAAI
RP-3500: A novel, potent and selective ATR inhibitor that is effective in pre-clinical models as a monotherapy and in combination with PARP inhibitors
2021-12-010
PRE
The CIP2A-TOPBP1 axis safeguards chromosome stability and is a synthetic lethal target for BRCA-mutated cancer
2021-11-1154
PRE
Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features (vol 9, 4181, 2018)
2019-01-142
OAAI
Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features

尼日利亚乳腺癌的表征揭示了普遍的同源重组缺陷和侵袭性分子特征

2018-10-1671
OAAI
Discovery and Optimization of HKT288, a Cadherin-6-Targeting ADC for the Treatment of Ovarian and Renal Cancers
2017-08-3143
OAAI